[go: up one dir, main page]

GB201411429D0 - Methods for monitoring treatment response and relapse in ovarian cancer - Google Patents

Methods for monitoring treatment response and relapse in ovarian cancer

Info

Publication number
GB201411429D0
GB201411429D0 GB201411429A GB201411429A GB201411429D0 GB 201411429 D0 GB201411429 D0 GB 201411429D0 GB 201411429 A GB201411429 A GB 201411429A GB 201411429 A GB201411429 A GB 201411429A GB 201411429 D0 GB201411429 D0 GB 201411429D0
Authority
GB
United Kingdom
Prior art keywords
relapse
methods
ovarian cancer
treatment response
monitoring treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB201411429A
Other versions
GB2519830A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AFG Technologies SARL
Original Assignee
AFG Technologies SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AFG Technologies SARL filed Critical AFG Technologies SARL
Publication of GB201411429D0 publication Critical patent/GB201411429D0/en
Publication of GB2519830A publication Critical patent/GB2519830A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57449Specifically defined cancers of ovaries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486Metalloendopeptidases (3.4.24)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB1411429.2A 2013-06-26 2014-06-26 Methods for monitoring treatment response and relapse in ovarian cancer Withdrawn GB2519830A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1311385.7A GB201311385D0 (en) 2013-06-26 2013-06-26 Method

Publications (2)

Publication Number Publication Date
GB201411429D0 true GB201411429D0 (en) 2014-08-13
GB2519830A GB2519830A (en) 2015-05-06

Family

ID=48999008

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1311385.7A Ceased GB201311385D0 (en) 2013-06-26 2013-06-26 Method
GB1411429.2A Withdrawn GB2519830A (en) 2013-06-26 2014-06-26 Methods for monitoring treatment response and relapse in ovarian cancer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB1311385.7A Ceased GB201311385D0 (en) 2013-06-26 2013-06-26 Method

Country Status (2)

Country Link
GB (2) GB201311385D0 (en)
WO (1) WO2014207170A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201311385D0 (en) * 2013-06-26 2013-08-14 Afg Technologies S R L Method
RU2637399C1 (en) * 2017-02-02 2017-12-04 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр" Российской академии наук ("Томский НИМЦ") Method for prediction of probability of possible execution of optimum cytoreductive operation in patients with disseminated forms of ovarian cancer
RU2658047C1 (en) * 2017-05-11 2018-06-19 Государственное автономное учреждение здравоохранения "Республиканский клинический онкологический диспансер Министерства здравоохранения Республики Татарстан" Method of estimation of risk of recurrency of ovarian cancer
RU2671409C2 (en) * 2017-12-05 2018-10-31 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) Method for prediction of cytoreductive surgery volume in patients with advanced ovarian cancer after completion of third course of neoadjuvant chemotherapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021686A1 (en) 1993-03-19 1994-09-29 Northern Sydney Area Health Service Papp-a, its immunodetection and uses
US7462458B2 (en) * 2002-05-15 2008-12-09 Mayo Foundation For Medical Education And Research Methods of detecting ovarian neoplasia
GB201311385D0 (en) * 2013-06-26 2013-08-14 Afg Technologies S R L Method

Also Published As

Publication number Publication date
GB2519830A (en) 2015-05-06
WO2014207170A1 (en) 2014-12-31
GB201311385D0 (en) 2013-08-14

Similar Documents

Publication Publication Date Title
GB201309568D0 (en) Methods and apparatus
PT3095044T (en) Block mining methods and apparatus
IL244510A0 (en) Cancer biomarkers and uses thereof
GB201310910D0 (en) The use of phytocannabinoids in the treatment of ovarian carcinoma
SG11201603050TA (en) Methods for treating cancers
EP2988208A4 (en) Application sharing method and device
IL244353A0 (en) Compounds and use for treating cancer
GB201604534D0 (en) Nucleic-acid-sequence determination device and nucleic-acid-sequence determination method
GB201317429D0 (en) Spectroscopy apparatus and method
EP2946614A4 (en) Methods and apparatus
LT3065828T (en) Methods and materials for treating hematological malignancies
PL3071192T3 (en) Curcuphenol compound for use in treating cancer
HUE048625T2 (en) Methods for treating cancer
GB201411429D0 (en) Methods for monitoring treatment response and relapse in ovarian cancer
GB201301728D0 (en) Telcommunications apparatus and methods
PL2986429T3 (en) Device and process for profils edge-banding
GB2519734B (en) Apparatus and Methods
GB201316737D0 (en) Apparatus and Methods
GB201307787D0 (en) Methods and Apparatus
GB201316896D0 (en) Processing Methods and cassette
AP2015008760A0 (en) Hydrocarbon-producing apparatus and hydrocarbon-producing method
GB2519829B (en) Methods for monitoring treatment response and relapse in breast cancer
IL246185A0 (en) Composihons and methods for treating disregulatel systems
GB2537485B (en) Apparatus and methods for selectively treating production zones
GB2532359B (en) Process and apparatus

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)